Original Research

A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease

McMullin D, Clark D, Cavanagh B, Karpecki P, Brady TC

Clinical Ophthalmology 2021, 15:3889-3900

Published Date: 22 September 2021